Shopping Cart
- Remove All
Your shopping cart is currently empty
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $32 | In Stock | |
| 10 mg | $46 | In Stock | |
| 25 mg | $84 | In Stock | |
| 50 mg | $126 | In Stock | |
| 100 mg | $173 | In Stock | |
| 200 mg | $282 | In Stock | |
| 500 mg | $413 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $50 | In Stock |
| Description | Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy. |
| Synonyms | Zebinix, Stedesa, Exalief, BIA 2-093, Aptiom |
| Molecular Weight | 296.32 |
| Formula | C17H16N2O3 |
| Cas No. | 236395-14-5 |
| Smiles | O(C(C)=O)[C@@H]1C=2C(N(C(N)=O)C=3C(C1)=CC=CC3)=CC=CC2 |
| Relative Density. | 1.32g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 9 mg/mL (30.37 mM), Sonication is recommended. DMSO: 40 mg/mL (134.99 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.